2021, Supplement 1
Cardiovasc Metab Sci 2021; 32 (S1)
Introduction First Mexican statement in Heart Failure
Magaña Serrano, José Antonio; Cigarroa López, José Ángel; Chávez Mendoza, Adolfo; Rayo Chávez, Jorge; Galván Oseguera, Héctor; Aguilera Mora, Luisa Fernanda; Ivey Miranda, Juan Betuel; Rascón Sabido, Rafael; Mendez Machado, Gustavo Francisco; Mendoza Zavala, Genaro Hiram; Olmos Dominguez, Luis; Chávez Leal, Sergio; Olalde Román, Marcos Jaciel; Fernández Muñoz, María de Jesús; Aceves García, Moisés; Pombo Bartelt, Ernesto; Pacheco Bouthillier, Alex Daniel; de León Larios, Gerardo; Coutiño,Hugo Enrique; Mariona Montero, Vitelio Augusto; González, Jorge; Hernández Rendón, Edgar; Álvarez San Gabriel, Amada; Álvarez Álvarez, Rolando Joel; Guízar Sánchez, Carlos Alberto; Araiza Garaygordobil, Diego; Herrera Garza, Eduardo Heberto; Castán Flores, David; Ruiz Ruiz, Vicente Eduardo; Tepayotl Aponte, Antonio; Gutiérrez Fajardo, Pedro; Borrayo Sánchez, Gabriela; Alcocer Gamba, Marco Antonio
ABSTRACT
Heart Failure has become the main concern in cardiovascular medicine in developed and emergent countries and Mexico is no exception. As such, it constitutes the common denominator of all the diseases that affect the cardiovascular system and therefore, the magnitude of the problem is enormous. In recent decades, great advances have been made in the diagnosis and treatment of heart failure, which have been reflected in the recommendations of current clinical practice guidelines. However, despite having excellent consensus documents, the magnitude of the problem and its impact on morbidity and mortality continue to increase.